SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-462036
Filing Date
2016-02-12
Accepted
2016-02-12 15:05:00
Documents
3
Group Members
BAXALTA GMBH

Document Format Files

Seq Description Document Type Size
1 SC 13G d138426dsc13g.htm SC 13G 53251
2 EX-99.1 d138426dex991.htm EX-99.1 4206
3 EX-99.2 d138426dex992.htm EX-99.2 7066
  Complete submission text file 0001193125-16-462036.txt   66242
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Subject) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87566 | Film No.: 161418189
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015 224-940-2000
Baxalta Inc (Filed by) CIK: 0001620546 (see all company filings)

IRS No.: 471869689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations